From the Guidelines
There is currently no robust scientific evidence supporting the effectiveness of the "allergy release technique" for treating allergies, and individuals with allergies should instead pursue evidence-based treatments such as allergen avoidance, antihistamines, nasal corticosteroids, or allergen immunotherapy (allergy shots) under medical supervision. The most recent and highest quality study, published in 2024 in the journal Otolaryngology--head and neck surgery, recommends allergen immunotherapy (AIT) as an effective treatment for allergic rhinitis (AR) and allergic asthma (AA) 1. This study highlights the benefits of AIT, including improved symptom control, reduced medication usage, and potential prevention of new sensitizations and asthma development.
Key benefits of AIT include:
- Improved symptom control and quality of life (QOL) for patients with AR and AA
- Reduction in medication usage, including inhaled corticosteroids (ICS) for mild to moderate asthma patients
- Potential prevention of new sensitizations and asthma development
- Cost savings compared to symptomatic medication use
The study also emphasizes the importance of shared decision-making between clinicians and patients, considering factors such as the need for long-term daily pharmacologic therapy and patient preference for immunomodulation 1. Additionally, the study recommends that clinicians discuss AIT options with patients who have inadequate control of symptoms with medical therapy, allergen avoidance, or both, or who have a preference for immunomodulation 1.
In contrast, alternative techniques like the allergy release technique lack established biological plausibility and have not been validated through rigorous clinical trials or peer-reviewed research. Therefore, individuals with allergies should consult with a board-certified allergist or immunologist for proper diagnosis and treatment rather than pursuing unproven alternative approaches. As noted in a recent clinical practice guideline, AIT can lead to lasting benefits even after stopping treatment, reducing the need for other medications and providing cost savings and convenience 1.
From the Research
Allergy Release Technique (ART) Evidence
There are no research papers to assist in answering this question, as none of the provided studies mention the allergy release technique (ART) for treating allergies.
Alternative Allergy Treatments
However, the studies do discuss various other treatments for allergies, including:
- Epinephrine, corticosteroids, and antihistamines for managing allergic reactions and anaphylaxis 2
- Oral antihistamines and intranasal corticosteroids for treating allergic rhinitis, with corticosteroids showing superior efficacy 3
- Fixed combinations of nasal antihistamines and corticosteroids, such as azelastine and fluticasone propionate, for treating allergic rhinitis 4
- Subcutaneous immunotherapy (SCIT) and dupilumab for treating seasonal allergic rhinitis, with SCIT+dupilumab showing improved tolerability but not incremental reduction in nasal symptoms 5
- Intranasal antihistamines and corticosteroids, with azelastine-fluticasone, fluticasone furoate, and fluticasone propionate showing high probability of resulting in moderate or large improvements in nasal symptom scores and quality of life 6